PHAT vs REG · rev $55.3M vs P/E 34, $12.93B cap
Phathom Pharmaceuticals Inc (PHAT) versus Regency Centers Corporation (REG) — a side-by-side from cached financials, not a winner call.
Phathom Pharmaceuticals Inc (PHAT) is a biotechnology company listed on US.
Regency Centers Corporation (REG) is a reit - retail company listed on US.
Latest reported PHAT revenue for 2024-12-31 was $55.3M. Net income was -$334.3M. Revenue was up 8001.5% from 2023-12-31 to 2024-12-31. PHAT currently screens at market cap $622.7M.
REG does not have a complete income-statement cache yet.
PHAT currently screens at market cap $622.7M. REG currently screens at market cap $12.93B and trailing P/E 33.5.
Not investment advice. Open the PHAT and REG stock pages for the full models.
Not investment advice.